Amalgamated Financial’s Collegium Pharmaceutical COLL Stock Holding History

Amalgamated Financial’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$343K	Buy	+16,849	New	+$318K	﹤0.01%	1679

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Amalgamated Financial's COLL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Collegium Pharmaceutical (COLL) in Q1 2022: 16,849 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #1679 among its holdings.

172 funds tracked by Wall St. Rank hold COLL as of Q1 2022.

Amalgamated Financial held 16,849 shares of Collegium Pharmaceutical worth $343K as of Q1 2022.
Collegium Pharmaceutical was a new Amalgamated Financial position in Q1 2022.
Collegium Pharmaceutical made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1679 holding.
172 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.